rs3746803

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033409.4(SLC52A3):​c.833C>T​(p.Thr278Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.106 in 1,614,094 control chromosomes in the GnomAD database, including 9,591 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T278K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.093 ( 700 hom., cov: 33)
Exomes 𝑓: 0.11 ( 8891 hom. )

Consequence

SLC52A3
NM_033409.4 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.57

Publications

24 publications found
Variant links:
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • progressive bulbar palsy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0018212199).
BP6
Variant 20-763738-G-A is Benign according to our data. Variant chr20-763738-G-A is described in ClinVar as Benign. ClinVar VariationId is 262240.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.124 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033409.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
NM_033409.4
MANE Select
c.833C>Tp.Thr278Met
missense
Exon 3 of 5NP_212134.3
SLC52A3
NM_001370085.1
c.833C>Tp.Thr278Met
missense
Exon 4 of 6NP_001357014.1Q9NQ40-1
SLC52A3
NM_001370086.1
c.833C>Tp.Thr278Met
missense
Exon 4 of 6NP_001357015.1Q9NQ40-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A3
ENST00000645534.1
MANE Select
c.833C>Tp.Thr278Met
missense
Exon 3 of 5ENSP00000494193.1Q9NQ40-1
SLC52A3
ENST00000217254.11
TSL:5
c.833C>Tp.Thr278Met
missense
Exon 4 of 6ENSP00000217254.7Q9NQ40-1
SLC52A3
ENST00000488495.3
TSL:3
c.833C>Tp.Thr278Met
missense
Exon 3 of 5ENSP00000494009.1Q9NQ40-1

Frequencies

GnomAD3 genomes
AF:
0.0931
AC:
14169
AN:
152174
Hom.:
699
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0732
Gnomad AMI
AF:
0.0186
Gnomad AMR
AF:
0.0690
Gnomad ASJ
AF:
0.122
Gnomad EAS
AF:
0.0840
Gnomad SAS
AF:
0.132
Gnomad FIN
AF:
0.109
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.0866
GnomAD2 exomes
AF:
0.101
AC:
25500
AN:
251306
AF XY:
0.105
show subpopulations
Gnomad AFR exome
AF:
0.0724
Gnomad AMR exome
AF:
0.0603
Gnomad ASJ exome
AF:
0.126
Gnomad EAS exome
AF:
0.0757
Gnomad FIN exome
AF:
0.113
Gnomad NFE exome
AF:
0.108
Gnomad OTH exome
AF:
0.101
GnomAD4 exome
AF:
0.108
AC:
157634
AN:
1461802
Hom.:
8891
Cov.:
35
AF XY:
0.109
AC XY:
79009
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.0662
AC:
2217
AN:
33480
American (AMR)
AF:
0.0626
AC:
2800
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.128
AC:
3350
AN:
26136
East Asian (EAS)
AF:
0.0809
AC:
3213
AN:
39696
South Asian (SAS)
AF:
0.139
AC:
11988
AN:
86256
European-Finnish (FIN)
AF:
0.113
AC:
6008
AN:
53404
Middle Eastern (MID)
AF:
0.0794
AC:
458
AN:
5768
European-Non Finnish (NFE)
AF:
0.109
AC:
121249
AN:
1111948
Other (OTH)
AF:
0.105
AC:
6351
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
9771
19542
29314
39085
48856
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4438
8876
13314
17752
22190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0931
AC:
14176
AN:
152292
Hom.:
700
Cov.:
33
AF XY:
0.0928
AC XY:
6908
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0732
AC:
3040
AN:
41556
American (AMR)
AF:
0.0691
AC:
1057
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.122
AC:
424
AN:
3470
East Asian (EAS)
AF:
0.0842
AC:
437
AN:
5190
South Asian (SAS)
AF:
0.133
AC:
640
AN:
4826
European-Finnish (FIN)
AF:
0.109
AC:
1157
AN:
10618
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.106
AC:
7203
AN:
68010
Other (OTH)
AF:
0.0862
AC:
182
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
691
1381
2072
2762
3453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.101
Hom.:
1734
Bravo
AF:
0.0878
TwinsUK
AF:
0.110
AC:
407
ALSPAC
AF:
0.114
AC:
440
ESP6500AA
AF:
0.0788
AC:
347
ESP6500EA
AF:
0.110
AC:
943
ExAC
AF:
0.104
AC:
12609
Asia WGS
AF:
0.126
AC:
439
AN:
3478
EpiCase
AF:
0.100
EpiControl
AF:
0.0953

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Brown-Vialetto-van Laere syndrome 1 (1)
-
-
1
Progressive bulbar palsy of childhood;C0796274:Brown-Vialetto-van Laere syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
11
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0048
T
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.50
T
MetaRNN
Benign
0.0018
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.55
N
PhyloP100
1.6
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.29
N
REVEL
Benign
0.10
Sift
Benign
0.11
T
Sift4G
Benign
0.11
T
Polyphen
0.47
P
Vest4
0.016
MPC
0.34
ClinPred
0.0038
T
GERP RS
2.4
Varity_R
0.019
gMVP
0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3746803; hg19: chr20-744382; COSMIC: COSV54076878; API